The current management of infectious diseases in the liver transplant recipient.
The spectrum of major infections after transplantation has undergone a striking evolution. The epidemiologic trends in infectious diseases through the last decade have been most notable for a dramatic decrease in the incidence of several opportunistic infections, largely because of advances in prophylaxis against these pathogens. Paralleling these trends has been an exponential rise in the proportion of infections caused by antimicrobial-resistant bacteria. These multiresistant organisms have now emerged as leading pathogens at many transplant centers, and their management is a daunting challenge.
Singh
N
N
Infectious Disease Section, Veterans Affairs Medical Center, Pittsburgh, Pennsylvania, USA.
D001424:Bacterial Infections / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D016031:Liver Transplantation; D009181:Mycoses / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D011528:Protozoan Infections / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy